We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Better Test for Infant Iron Deficiency

By HospiMedica staff writers
Posted on 05 Sep 2005
A new blood test detects iron deficiency in infants earlier and more accurately than the commonly used hemoglobin screening test, a recent study has found.

Iron deficiency is estimated to affect nearly 10% of U.S. More...
children one to two years of age. Early detection and treatment are important since iron deficiency can impair the mental development of infants, sometimes permanently, even before the deficiency progresses to anemia.

In the study, researchers at Children's Hospital Boston (MA, USA) compared the new test, called CHr, with the standard hemoglobin test as a screen for iron deficiency in infants. CHr measures the hemoglobin content of reticulocytes, or immature red blood cells, while the standard hemoglobin test is based on the entire population of red blood cells. Since reticulocytes are present in the bloodstream for only 24-48 hours, compared to several months for mature red blood cells, measuring reticulocyte hemoglobin content provides a more up-to-date indication of iron status, said the investigators.

In the study, 200 healthy infants nine-12 years of age underwent both tests, as well as a transferring saturation test, considered the "gold standard” for iron deficiency but impractical for routine screening. Using the optimal CHr cutoff, CHr correctly identified 83% of the iron-deficient infants, compared with only 26% identified by the current screening standard. The results were reported in the August 24/31, 2005, issue of the Journal of the American Medical Association.

"Our findings are important because, while iron deficiency can be readily treated, practitioners haven't had a simple, reliable, and practical screening test to detect it early enough,” said principal investigator Henry Bernstein, D.O., associate chief, general pediatrics, Children's Hospital Boston. "Once confirmed in larger, multicenter studies, these findings could change our preferred screening practices for the early detection of iron deficiency.” He added that the CHr test is simple, requires no extra tubes of blood to be drawn, and involves no extra cost.



Related Links:
Children's Hospital Boston

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Exam Table
PF400
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.